NCT01168921 2023-03-23Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)M.D. Anderson Cancer CenterPhase 2 Completed23 enrolled 9 charts
NCT01890746 2019-09-11A Safety and Efficacy Study of Eltrombopag in Subjects With AMLNovartisPhase 2 Completed148 enrolled 42 charts
NCT01610180 2018-07-16Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)Fondazione Progetto EmatologiaPhase 2 Completed18 enrolled